Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC
Clinical trial NCT02179567 · TERMINATED
Trial details
- NCT number
- NCT02179567
- Sponsor
- Hellenic Oncology Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.